CI
AGN

Clal Insurance’s Allergan plc AGN Stock Holding History

Clal Insurance’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-177,000
Closed -$42.3M – 73
2017
Q1 		$42.3M Hold
177,000
– – 0.86% 24
2016
Q4 		$37.2M Sell
177,000
-10,801
-6% -$2.24M 0.7% 22
2016
Q3 		$43.3M Hold
187,801
– – 0.98% 15
2016
Q2 		$43.4M Hold
187,801
– – 1.1% 26
2016
Q1 		$50.3M Buy
187,801
+78,501
+72% +$22.5M 1.47% 23
2015
Q4 		$34.2M Buy
109,300
+27,275
+33% +$8.12M 0.91% 32
2015
Q3 		$22.3M Buy
82,025
+40,550
+98% +$12.5M 0.58% 42
2015
Q2 		$12.6M Hold
41,475
– – 0.29% 54
2015
Q1 		$12.3M Buy
+41,475
New +$11.8M 0.28% 53

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Clal Insurance's AGN Position: Q2 2017 in Review

Clal Insurance sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 177,000 shares — an estimated $42.3M sold.

Clal Insurance first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $50.3M in Q1 2016. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Clal Insurance reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Clal Insurance sold 177,000 Allergan plc shares in Q2 2017, an estimated $42.3M.
  • Clal Insurance first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Clal Insurance's Allergan plc position peaked at $50.3M in Q1 2016.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Clal Insurance's 13F filing for Q2 2017, filed 9 Aug 2017.